Global Blood Cell Analyzer

Blood Cell Analyzer Comprehensive Study by Type (Semi-automated Biochemistry Analyzers, Fully Automated Biochemistry Analyzers), Application (Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes), Throughput (Less than 50 Samples/hour, 51 – 100 Samples/hour, 101 – 150 Samples/hour, More than 151 Samples/hour) Players and Region - Global Market Outlook to 2028

Blood Cell Analyzer Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Blood Cell Analyzer Market Scope
A blood cell analyzer, also known as a hematology analyzer or blood cell counter, is a medical device used in clinical laboratories to analyze and quantify different types of blood cells present in a patient's blood sample. It is an essential tool for diagnosing and monitoring various hematological conditions and disorders. Blood cell analyzers automate the process of blood cell counting and provide detailed information about the different types and quantities of blood cells, such as red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes). Some analyzers can also provide additional parameters, such as cell size, cell morphology, hemoglobin levels, and other characteristics of the blood cells.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledSysmex Corporation (Japan), Abbott Laboratories (United States), Danaher Corporation (United States), Siemens Healthcare (Germany), Horiba Ltd (Japan), Bio-Rad Laboratories (United States), F. Hoffmann-La Roche (Switzerland), Sigma Aldrich (United States), Boule Diagnostics (Sweden) and Johnson & Johnson (United States)
CAGR%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Blood Cell Analyzer market throughout the predicted period.

Sysmex Corporation (Japan), Abbott Laboratories (United States), Danaher Corporation (United States), Siemens Healthcare (Germany), Horiba Ltd (Japan), Bio-Rad Laboratories (United States), F. Hoffmann-La Roche (Switzerland), Sigma Aldrich (United States), Boule Diagnostics (Sweden) and Johnson & Johnson (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Johnson & Johnson (United States), Celularity Inc. (United States), Nihon Kohden Corporation (Japan), Beckman Coulter Inc. (United States) and Diatron MI PLC (Hungary).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Blood Cell Analyzer market by Type , by Application (Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes) and Region with country level break-up.

On the basis of geography, the market of Blood Cell Analyzer has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies

On 8th March 2018 - Roche Launched a New Cobas M 511 Analyzer, Signaling A New Era in Hematology Testing, Followed by 510(k) Clearance from The U.S. Food and Drug Administration (FDA). The Device Combines a Cell Counter, Slide Maker, and Stainer And A Digital Morphology Analyzer into One Integrated Solution. and On 1st February 2021 - Beckman Coulter Introduces Tabletop Hematology Analyzer, The DxH 560 AL produces results in less than 60 seconds. Since it only needs a 17-liter sample (less than a drop in blood), it can be used for difficult-to-draw patients (infants, oncology, and the elderly).


Influencing Trend:
Technical Progress in Healthcare Industry

Market Growth Drivers:
Prevalence of Blood Clot Related Disorders and Rising Geriatric Population

Challenges:
Highly Priced Procedures

Restraints:
Lack of Trained Professionals

Opportunities:
Emergence of Efficient Techniques

Key Target Audience
Blood Cell Analyzer Manufactures, New Entrants and Investors, Blood Cell Analyzer Distributors and Suppliers, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Semi-automated Biochemistry Analyzers
  • Fully Automated Biochemistry Analyzers
By Application
  • Hospitals
  • Diagnostic Centers
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
By Throughput
  • Less than 50 Samples/hour
  • 51 – 100 Samples/hour
  • 101 – 150 Samples/hour
  • More than 151 Samples/hour

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevalence of Blood Clot Related Disorders
      • 3.2.2. Rising Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Highly Priced Procedures
    • 3.4. Market Trends
      • 3.4.1. Technical Progress in Healthcare Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Cell Analyzer, by Type, Application, Throughput and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Blood Cell Analyzer (Value)
      • 5.2.1. Global Blood Cell Analyzer by: Type (Value)
        • 5.2.1.1. Semi-automated Biochemistry Analyzers
        • 5.2.1.2. Fully Automated Biochemistry Analyzers
      • 5.2.2. Global Blood Cell Analyzer by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Diagnostic Centers
        • 5.2.2.3. Pharmaceutical Companies
        • 5.2.2.4. Biotechnology Companies
        • 5.2.2.5. Contract Research Organizations
        • 5.2.2.6. Academic Research Institutes
      • 5.2.3. Global Blood Cell Analyzer by: Throughput (Value)
        • 5.2.3.1. Less than 50 Samples/hour
        • 5.2.3.2. 51 – 100 Samples/hour
        • 5.2.3.3. 101 – 150 Samples/hour
        • 5.2.3.4. More than 151 Samples/hour
      • 5.2.4. Global Blood Cell Analyzer Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Blood Cell Analyzer: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sysmex Corporation (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott Laboratories (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Danaher Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Siemens Healthcare (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Horiba Ltd (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio-Rad Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. F. Hoffmann-La Roche (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sigma Aldrich (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Boule Diagnostics (Sweden)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Johnson & Johnson (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Cell Analyzer Sale, by Type, Application, Throughput and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Blood Cell Analyzer (Value)
      • 7.2.1. Global Blood Cell Analyzer by: Type (Value)
        • 7.2.1.1. Semi-automated Biochemistry Analyzers
        • 7.2.1.2. Fully Automated Biochemistry Analyzers
      • 7.2.2. Global Blood Cell Analyzer by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Diagnostic Centers
        • 7.2.2.3. Pharmaceutical Companies
        • 7.2.2.4. Biotechnology Companies
        • 7.2.2.5. Contract Research Organizations
        • 7.2.2.6. Academic Research Institutes
      • 7.2.3. Global Blood Cell Analyzer by: Throughput (Value)
        • 7.2.3.1. Less than 50 Samples/hour
        • 7.2.3.2. 51 – 100 Samples/hour
        • 7.2.3.3. 101 – 150 Samples/hour
        • 7.2.3.4. More than 151 Samples/hour
      • 7.2.4. Global Blood Cell Analyzer Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Cell Analyzer: by Type(USD Million)
  • Table 2. Blood Cell Analyzer Semi-automated Biochemistry Analyzers , by Region USD Million (2017-2022)
  • Table 3. Blood Cell Analyzer Fully Automated Biochemistry Analyzers , by Region USD Million (2017-2022)
  • Table 4. Blood Cell Analyzer: by Application(USD Million)
  • Table 5. Blood Cell Analyzer Hospitals , by Region USD Million (2017-2022)
  • Table 6. Blood Cell Analyzer Diagnostic Centers , by Region USD Million (2017-2022)
  • Table 7. Blood Cell Analyzer Pharmaceutical Companies , by Region USD Million (2017-2022)
  • Table 8. Blood Cell Analyzer Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 9. Blood Cell Analyzer Contract Research Organizations , by Region USD Million (2017-2022)
  • Table 10. Blood Cell Analyzer Academic Research Institutes , by Region USD Million (2017-2022)
  • Table 11. Blood Cell Analyzer: by Throughput(USD Million)
  • Table 12. Blood Cell Analyzer Less than 50 Samples/hour , by Region USD Million (2017-2022)
  • Table 13. Blood Cell Analyzer 51 – 100 Samples/hour , by Region USD Million (2017-2022)
  • Table 14. Blood Cell Analyzer 101 – 150 Samples/hour , by Region USD Million (2017-2022)
  • Table 15. Blood Cell Analyzer More than 151 Samples/hour , by Region USD Million (2017-2022)
  • Table 16. South America Blood Cell Analyzer, by Country USD Million (2017-2022)
  • Table 17. South America Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 18. South America Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 19. South America Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 20. Brazil Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 21. Brazil Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 22. Brazil Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 23. Argentina Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 24. Argentina Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 25. Argentina Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 26. Rest of South America Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 27. Rest of South America Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 28. Rest of South America Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 29. Asia Pacific Blood Cell Analyzer, by Country USD Million (2017-2022)
  • Table 30. Asia Pacific Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 31. Asia Pacific Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 32. Asia Pacific Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 33. China Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 34. China Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 35. China Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 36. Japan Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 37. Japan Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 38. Japan Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 39. India Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 40. India Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 41. India Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 42. South Korea Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 43. South Korea Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 44. South Korea Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 45. Taiwan Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 46. Taiwan Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 47. Taiwan Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 48. Australia Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 49. Australia Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 50. Australia Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 54. Europe Blood Cell Analyzer, by Country USD Million (2017-2022)
  • Table 55. Europe Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 56. Europe Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 57. Europe Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 58. Germany Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 59. Germany Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 60. Germany Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 61. France Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 62. France Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 63. France Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 64. Italy Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 65. Italy Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 66. Italy Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 67. United Kingdom Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 68. United Kingdom Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 69. United Kingdom Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 70. Netherlands Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 71. Netherlands Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 72. Netherlands Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 73. Rest of Europe Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 74. Rest of Europe Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 75. Rest of Europe Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 76. MEA Blood Cell Analyzer, by Country USD Million (2017-2022)
  • Table 77. MEA Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 78. MEA Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 79. MEA Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 80. Middle East Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 81. Middle East Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 82. Middle East Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 83. Africa Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 84. Africa Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 85. Africa Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 86. North America Blood Cell Analyzer, by Country USD Million (2017-2022)
  • Table 87. North America Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 88. North America Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 89. North America Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 90. United States Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 91. United States Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 92. United States Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 93. Canada Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 94. Canada Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 95. Canada Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 96. Mexico Blood Cell Analyzer, by Type USD Million (2017-2022)
  • Table 97. Mexico Blood Cell Analyzer, by Application USD Million (2017-2022)
  • Table 98. Mexico Blood Cell Analyzer, by Throughput USD Million (2017-2022)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Blood Cell Analyzer: by Type(USD Million)
  • Table 110. Blood Cell Analyzer Semi-automated Biochemistry Analyzers , by Region USD Million (2023-2028)
  • Table 111. Blood Cell Analyzer Fully Automated Biochemistry Analyzers , by Region USD Million (2023-2028)
  • Table 112. Blood Cell Analyzer: by Application(USD Million)
  • Table 113. Blood Cell Analyzer Hospitals , by Region USD Million (2023-2028)
  • Table 114. Blood Cell Analyzer Diagnostic Centers , by Region USD Million (2023-2028)
  • Table 115. Blood Cell Analyzer Pharmaceutical Companies , by Region USD Million (2023-2028)
  • Table 116. Blood Cell Analyzer Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 117. Blood Cell Analyzer Contract Research Organizations , by Region USD Million (2023-2028)
  • Table 118. Blood Cell Analyzer Academic Research Institutes , by Region USD Million (2023-2028)
  • Table 119. Blood Cell Analyzer: by Throughput(USD Million)
  • Table 120. Blood Cell Analyzer Less than 50 Samples/hour , by Region USD Million (2023-2028)
  • Table 121. Blood Cell Analyzer 51 – 100 Samples/hour , by Region USD Million (2023-2028)
  • Table 122. Blood Cell Analyzer 101 – 150 Samples/hour , by Region USD Million (2023-2028)
  • Table 123. Blood Cell Analyzer More than 151 Samples/hour , by Region USD Million (2023-2028)
  • Table 124. South America Blood Cell Analyzer, by Country USD Million (2023-2028)
  • Table 125. South America Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 126. South America Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 127. South America Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 128. Brazil Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 129. Brazil Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 130. Brazil Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 131. Argentina Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 132. Argentina Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 133. Argentina Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 134. Rest of South America Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 135. Rest of South America Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 136. Rest of South America Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 137. Asia Pacific Blood Cell Analyzer, by Country USD Million (2023-2028)
  • Table 138. Asia Pacific Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 139. Asia Pacific Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 140. Asia Pacific Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 141. China Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 142. China Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 143. China Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 144. Japan Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 145. Japan Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 146. Japan Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 147. India Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 148. India Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 149. India Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 150. South Korea Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 151. South Korea Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 152. South Korea Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 153. Taiwan Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 154. Taiwan Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 155. Taiwan Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 156. Australia Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 157. Australia Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 158. Australia Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 160. Rest of Asia-Pacific Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 161. Rest of Asia-Pacific Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 162. Europe Blood Cell Analyzer, by Country USD Million (2023-2028)
  • Table 163. Europe Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 164. Europe Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 165. Europe Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 166. Germany Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 167. Germany Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 168. Germany Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 169. France Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 170. France Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 171. France Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 172. Italy Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 173. Italy Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 174. Italy Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 175. United Kingdom Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 176. United Kingdom Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 177. United Kingdom Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 178. Netherlands Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 179. Netherlands Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 180. Netherlands Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 181. Rest of Europe Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 182. Rest of Europe Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 183. Rest of Europe Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 184. MEA Blood Cell Analyzer, by Country USD Million (2023-2028)
  • Table 185. MEA Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 186. MEA Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 187. MEA Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 188. Middle East Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 189. Middle East Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 190. Middle East Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 191. Africa Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 192. Africa Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 193. Africa Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 194. North America Blood Cell Analyzer, by Country USD Million (2023-2028)
  • Table 195. North America Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 196. North America Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 197. North America Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 198. United States Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 199. United States Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 200. United States Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 201. Canada Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 202. Canada Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 203. Canada Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 204. Mexico Blood Cell Analyzer, by Type USD Million (2023-2028)
  • Table 205. Mexico Blood Cell Analyzer, by Application USD Million (2023-2028)
  • Table 206. Mexico Blood Cell Analyzer, by Throughput USD Million (2023-2028)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Cell Analyzer: by Type USD Million (2017-2022)
  • Figure 5. Global Blood Cell Analyzer: by Application USD Million (2017-2022)
  • Figure 6. Global Blood Cell Analyzer: by Throughput USD Million (2017-2022)
  • Figure 7. South America Blood Cell Analyzer Share (%), by Country
  • Figure 8. Asia Pacific Blood Cell Analyzer Share (%), by Country
  • Figure 9. Europe Blood Cell Analyzer Share (%), by Country
  • Figure 10. MEA Blood Cell Analyzer Share (%), by Country
  • Figure 11. North America Blood Cell Analyzer Share (%), by Country
  • Figure 12. Global Blood Cell Analyzer share by Players 2022 (%)
  • Figure 13. Global Blood Cell Analyzer share by Players (Top 3) 2022(%)
  • Figure 14. Global Blood Cell Analyzer share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 17. Sysmex Corporation (Japan) Revenue: by Geography 2022
  • Figure 18. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 20. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Danaher Corporation (United States) Revenue: by Geography 2022
  • Figure 22. Siemens Healthcare (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Siemens Healthcare (Germany) Revenue: by Geography 2022
  • Figure 24. Horiba Ltd (Japan) Revenue, Net Income and Gross profit
  • Figure 25. Horiba Ltd (Japan) Revenue: by Geography 2022
  • Figure 26. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 27. Bio-Rad Laboratories (United States) Revenue: by Geography 2022
  • Figure 28. F. Hoffmann-La Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. F. Hoffmann-La Roche (Switzerland) Revenue: by Geography 2022
  • Figure 30. Sigma Aldrich (United States) Revenue, Net Income and Gross profit
  • Figure 31. Sigma Aldrich (United States) Revenue: by Geography 2022
  • Figure 32. Boule Diagnostics (Sweden) Revenue, Net Income and Gross profit
  • Figure 33. Boule Diagnostics (Sweden) Revenue: by Geography 2022
  • Figure 34. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 35. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 36. Global Blood Cell Analyzer: by Type USD Million (2023-2028)
  • Figure 37. Global Blood Cell Analyzer: by Application USD Million (2023-2028)
  • Figure 38. Global Blood Cell Analyzer: by Throughput USD Million (2023-2028)
  • Figure 39. South America Blood Cell Analyzer Share (%), by Country
  • Figure 40. Asia Pacific Blood Cell Analyzer Share (%), by Country
  • Figure 41. Europe Blood Cell Analyzer Share (%), by Country
  • Figure 42. MEA Blood Cell Analyzer Share (%), by Country
  • Figure 43. North America Blood Cell Analyzer Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Sysmex Corporation (Japan)
  • Abbott Laboratories (United States)
  • Danaher Corporation (United States)
  • Siemens Healthcare (Germany)
  • Horiba Ltd (Japan)
  • Bio-Rad Laboratories (United States)
  • F. Hoffmann-La Roche (Switzerland)
  • Sigma Aldrich (United States)
  • Boule Diagnostics (Sweden)
  • Johnson & Johnson (United States)
Additional players considered in the study are as follows:
Johnson & Johnson (United States) , Celularity Inc. (United States) , Nihon Kohden Corporation (Japan) , Beckman Coulter Inc. (United States) , Diatron MI PLC (Hungary)
Select User Access Type

Key Highlights of Report


Jun 2023 215 Pages 84 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Blood Cell Analyzer Quantitative research analysis
Global Blood Cell Analyzer Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Blood Cell Analyzer Market are by type [Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers], by end use application [Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes].
The Blood Cell Analyzer Market is gaining popularity and expected to see strong valuation by 2028.
  • Prevalence of Blood Clot Related Disorders
  • Rising Geriatric Population

Know More About Global Blood Cell Analyzer Report?

Have a Query? Click Here

Other Related Reports

Synthetic Biology Comprehensive Study by Type (Core Products {Synthetic DNA, Synthetic Cells, Synthetic Genes, XNA and Chassis Organisms}, Enabling Products {DNA Synthesis and Oligonucleotide Synthes...
$ 3750
DNA Polymerase Comprehensive Study by Type (Prokaryotic DNA polymerase, Eukaryotic DNA polymerase), Application (DNA Cloning, SNP Analysis, Next Generation Sequencing Applications, Other), End-User (...
$ 3650
Hepcidin Comprehensive Study by Type (DS-79182026, M-009, PRS-080, PTG-300, Others), Application (Acute Inflammation, Anemia, Iron Deficiency Anemia, Sickle Cell Disease, Others), End-Use (Hospitals,...
$ 3450
Stem Cell Antibody Comprehensive Study by Type (Primary Antibodies, Secondary Antibodies), Application (Developmental biology, Disease modeling research, Drug development screening, Cell therapy stud...
$ 3750
Transfection Reagents Comprehensive Study by Type (Reagents, Instruments), Application (Biomedical Research, Gene Expression Studies, Cancer Research, Transgenic Model, Protein Production, Therapeuti...
$ 3750
Radiopharmaceuticals in Nuclear Medicine Comprehensive Study by Type (Diagnostic Nuclear Medicine (PECT Radiopharmaceuticals, PET Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, ...
$ 3750